2014-16年抗生素耐药性调查(SOAR)俄罗斯结果
该调查测定了2014-16年俄罗斯分离的279株肺炎链球菌和279株流感嗜血杆菌的最低抑菌浓度,并按CLSI、EUCAST及PK/PD折点判定敏感性。肺炎链球菌对口服青霉素、大环内酯类和复方磺胺甲噁唑敏感性低,但对氟喹诺酮类全部敏感,对阿莫西林、阿莫西林/克拉维酸和头孢曲松敏感性≥92.8%。流感嗜血杆菌对头孢曲松全部敏感,对氨苄西林、头孢克洛、克拉霉素和复方磺胺甲噁唑敏感性降低。
要点
- 肺炎链球菌对口服青霉素敏感率为67.0%(CLSI口服/EUCAST折点),对氟喹诺酮类全部敏感。
- 肺炎链球菌对阿莫西林、阿莫西林/克拉维酸和头孢曲松敏感性≥92.8%(CLSI及PK/PD折点)。
- 流感嗜血杆菌15.4%产β-内酰胺酶,对头孢曲松全部敏感,对复方磺胺甲噁唑仅62.7%敏感。
核心结论
- 俄罗斯肺炎链球菌对口服青霉素、大环内酯类和复方磺胺甲噁唑敏感性低,但对氟喹诺酮类全部敏感,对阿莫西林、阿莫西林/克拉维酸和头孢曲松敏感性≥92.8%。
- 流感嗜血杆菌仅对氨苄西林、头孢克洛、克拉霉素和复方磺胺甲噁唑敏感性降低。
- CLSI、EUCAST和PK/PD折点间存在差异,尤其见于头孢克洛、头孢呋辛和大环内酯类;这些数据提示需进一步努力协调国际折点。
研究设计与样本
- 2014-16年从俄罗斯收集肺炎链球菌和流感嗜血杆菌分离株,共279株肺炎链球菌和279株流感嗜血杆菌。
- 采用CLSI肉汤微量稀释法测定MIC,并使用CLSI、EUCAST和药代动力学/药效学(PK/PD)折点评估敏感性。
主要发现
- 肺炎链球菌:67.0%对青霉素敏感(CLSI口服/EUCAST折点),93.2%对青霉素敏感(CLSI静脉折点);对氟喹诺酮类全部敏感。
- 肺炎链球菌按CLSI标准对头孢呋辛、头孢克洛、大环内酯类和复方磺胺甲噁唑的敏感率分别为85.0%、76.7%、68.8%和67.7%。
- 肺炎链球菌对阿莫西林、阿莫西林/克拉维酸和头孢曲松敏感性≥92.8%(CLSI及PK/PD折点);除氟喹诺酮类外,青霉素耐药株对所有药物敏感性≤60%。
- 流感嗜血杆菌:全部279株对头孢曲松敏感,15.4%产β-内酰胺酶,≥97.5%对阿莫西林/克拉维酸敏感(CLSI、EUCAST和PK/PD折点);4株按现行EUCAST标准对氟喹诺酮类非敏感。
- 流感嗜血杆菌对阿奇霉素敏感性在CLSI(99.3%)与EUCAST及PK/PD(2.2%)折点间存在重大差异;对复方磺胺甲噁唑敏感性低(62.7%敏感)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine antibiotic susceptibility in isolates of Streptococcus pneumoniae and Haemophilus influenzae collected in 2014-16 from Russia. METHODS: MICs were determined by CLSI broth microdilution and susceptibility was assessed using CLSI, EUCAST and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints. RESULTS: A total of 279 S. pneumoniae and 279 H. influenzae were collected. Overall, 67.0% of S. pneumoniae were penicillin susceptible by CLSI oral/EUCAST and 93.2% by CLSI intravenous (iv) breakpoints. All were fluoroquinolone susceptible, with amoxicillin, amoxicillin/clavulanic acid and ceftriaxone susceptibility ≥92.8% by CLSI and PK/PD breakpoints. Isolates showed lower susceptibility to cefuroxime, cefaclor, macrolides and trimethoprim/sulfamethoxazole by CLSI criteria: 85.0%, 76.7%, 68.8% and 67.7%, respectively. Generally, susceptibility was slightly lower by EUCAST criteria, except for cefaclor, for which the difference in susceptibility was much greater. Penicillin-resistant isolates had low susceptibility (≤60%) to all agents except fluoroquinolones. All 279 H. influenzae were ceftriaxone susceptible, 15.4% were β-lactamase positive and ≥97.5% were amoxicillin/clavulanic acid susceptible (CLSI, EUCAST and PK/PD breakpoints). Four isolates were fluoroquinolone non-susceptible by current EUCAST criteria. A major discrepancy was found with azithromycin susceptibility between CLSI (99.3%) and EUCAST and PK/PD (2.2%) breakpoints. Trimethoprim/sulfamethoxazole was poorly active (62.7% susceptible). CONCLUSIONS: Susceptibility to penicillin (oral), macrolides and trimethoprim/sulfamethoxazole was low in S. pneumoniae from Russia. However, isolates were fully susceptible to fluoroquinolones and ≥92.8% were susceptible to amoxicillin, amoxicillin/clavulanic acid and ceftriaxone. Isolates of H. influenzae only showed reduced susceptibility to ampicillin, cefaclor, clarithromycin and trimethoprim/sulfamethoxazole. Some differences were detected between CLSI, EUCAST and PK/PD breakpoints, especially with cefaclor, cefuroxime and macrolides. These data suggest further efforts are required to harmonize international breakpoints.
引用
- Torumkuney D, Mayanskiy N, Edelstein M, et al. Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Russia. J Antimicrob Chemother. 2018. PMID: 29659881. doi:10.1093/jac/dky065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。